Early onset Parkinson disease
Clinical trials for Early onset Parkinson disease explained in plain language.
Never miss a new study
Get alerted when new Early onset Parkinson disease trials appear
Sign up with your email to follow new studies for Early onset Parkinson disease, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Brain gene therapy aims to boost dopamine in young Parkinson's patients
Disease control Not yet recruitingThis early-stage trial tests a gene therapy called AAV2-hAADC in 9 adults with young-onset Parkinson's disease. The therapy delivers a gene directly to two brain regions (putamen and caudate) to help convert levodopa into dopamine more efficiently. The main goal is to check safet…
Matched conditions: EARLY ONSET PARKINSON DISEASE
Phase 1 • Sponsor: Krzysztof Bankiewicz • Aim: Disease control
Last updated Aug 29, 2026 00:00 UTC
-
Can a new pill slow Parkinson's symptoms?
Disease control Not yet recruitingThis clinical trial is testing an experimental medication called TJ0113 in people with early-onset Parkinson's disease. The study aims to see if TJ0113 can improve movement symptoms compared to a placebo. About 300 participants will take either TJ0113 or a placebo for 26 weeks, f…
Matched conditions: EARLY ONSET PARKINSON DISEASE
Phase 3 • Sponsor: Hangzhou PhecdaMed Co., Ltd. • Aim: Disease control
Last updated Aug 14, 2026 00:00 UTC